These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8450449)

  • 1. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.
    Kroboth PD; Bertz RJ; Smith RB
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1047-55. PubMed ID: 8450449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
    Rush CR; Higgins ST; Bickel WK; Hughes JR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1218-26. PubMed ID: 8450459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam.
    Smith RB; Kroboth PD; Folan MM; Kroboth FJ; Rosanske TW
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):422-9. PubMed ID: 8225690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.
    Bertz RJ; Kroboth PD; Kroboth FJ; Reynolds IJ; Salek F; Wright CE; Smith RB
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1317-29. PubMed ID: 9190868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
    Mandema JW; Wada DR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons.
    Weerts EM; Ator NA; Kaminski BJ; Griffiths RR
    Eur J Pharmacol; 2005 Sep; 519(1-2):103-13. PubMed ID: 16129429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative-stimulus effects of triazolam in women and men.
    Vansickel AR; Hays LR; Rush CR
    Am J Drug Alcohol Abuse; 2006; 32(3):329-49. PubMed ID: 16864467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.
    Andreu N; Chalé JJ; Senard JM; Thalamas C; Montastruc JL; Rascol O
    Clin Neuropharmacol; 1999; 22(1):15-23. PubMed ID: 10047929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative-stimulus effects of triazolam in light and moderate drinkers.
    Rush CR; Kelly TH; Fillmore MT; Hays LR
    Alcohol Clin Exp Res; 2003 Apr; 27(4):638-46. PubMed ID: 12711926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of triazolam after intravenous administration.
    Smith RB; Kroboth PD; Varner PD
    J Clin Pharmacol; 1987 Dec; 27(12):971-9. PubMed ID: 3437069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.
    Barbanoj MJ; Urbano G; Antonijoan R; Ballester MR; Valle M
    Neuropsychobiology; 2007; 55(3-4):203-12. PubMed ID: 17878744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.
    Bagli M; Süverkrüp R; Quadflieg R; Höflich G; Kasper S; Möller HJ; Langer M; Barlage U; Rao ML
    J Pharmacol Exp Ther; 1999 Nov; 291(2):547-54. PubMed ID: 10525070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.